Guangzhou Baiyunshan Pharmaceutical Holdings
600332.SS
#3193
Rank
NZ$8.65 B
Marketcap
NZ$5.33
Share price
1.42%
Change (1 day)
-15.34%
Change (1 year)

Earnings for Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SS)

Earnings in 2026 (TTM): NZ$0.73 Billion

According to Guangzhou Baiyunshan Pharmaceutical Holdings's latest financial reports the company's current earnings are NZ$11.14 Billion. In 2024 the company made an earning of NZ$0.89 Billion a decrease over its 2023 earnings that were of NZ$1.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guangzhou Baiyunshan Pharmaceutical Holdings from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.73 B
2024 NZ$0.89 B-30.8%
2023 NZ$1.29 B-4.38%
2022 NZ$1.35 B4.32%
2021 NZ$1.29 B35.17%
2020 NZ$0.96 B-10.54%
2019 NZ$1.07 B-1.38%
2018 NZ$1.08 B64.22%
2017 NZ$0.66 B27.61%
2016 NZ$0.51 B12.59%
2015 NZ$0.46 B9.34%
2014 NZ$0.42 B6.26%
2013 NZ$0.39 B162.26%
2012 NZ$0.15 B63.15%
2011 NZ$92.77 M9.1%
2010 NZ$85.02 M40.76%
2009 NZ$60.4 M9.3%
2008 NZ$55.26 M-50.94%
2007 NZ$0.11 B32.74%
2006 NZ$84.85 M26.99%
2005 NZ$66.82 M84.93%
2004 NZ$36.13 M-41.1%
2003 NZ$61.35 M-0.86%
2002 NZ$61.88 M